For reasons that remain unclear, kidney cancer risk was higher in users of GLP-1 agonists, particularly those under 65 and ...

Serena Williams has been taking a GLP-1 medication to help with her recent weight loss, she revealed for the first time in an ...

With 23 Grand Slam singles titles and four Olympic gold medals, Serena Williams is undeniably a superathlete. But the 43-year ...

Originally appeared on E! Online Serena Williams is serving up an honest look into her weight ...

She changed her diet and maintained a strict workout regimen. But since there were no results, Williams turned to GLP-1 ...

Serena Williams recently detailed her weight loss journey, sharing that she lost 31 pounds with the assistance of a GLP-1 ...

GLP-1 receptor agonists may reduce cancer risk among people with obesity or overweight, according to retrospective study results.Adults who used GLP-1 medications exhibited a statistically significant ...

GLP-1 receptor agonists may outperform metformin in lowering the risk for dementia, particularly Alzheimer’s disease and other nonvascular types, in patients with type 2 diabetes.

Employers are about to spend a lot more on health insurance next year as they shoulder higher costs driven by GLP-1 drugs, ...

Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing cancer risk among patients with obesity, particularly for endometrial, ovarian, and meningioma cancers.

Everyone is allowed to have their own opinion. But it’s important for me to own my own narrative and tell my own story.” ...